Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 21-28, March 2008

Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?

  • Cheryl L. Willman, MD (The Maurice and Marguerite Liberman Distinguished Chair in Cancer Research Director & CEO)

      Affiliations

    • Corresponding Author InformationTel.: +1 505 272 5622; Fax: +1 505 272 4039.

University of New Mexico Cancer Center, Cancer Research Facility, 2325 Camino de Salud NE, Room G03, Albuquerque, NM 87131, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(07)00098-9

doi:10.1016/j.beha.2007.11.008

Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 21-28, March 2008

Article Tools

* Image Usage & Resolution